Kevin Caliendo
Stock Analyst at UBS
(4.55)
# 155
Out of 4,814 analysts
170
Total ratings
68.75%
Success rate
11.99%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintains: Neutral | $23 → $21 | $15.19 | +38.25% | 2 | Mar 10, 2025 | |
| HSIC Henry Schein | Maintains: Neutral | $83 → $80 | $64.28 | +24.46% | 5 | Feb 26, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $25 → $13 | $6.65 | +95.49% | 5 | Feb 13, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $330 → $305 | $322.37 | -5.39% | 3 | Feb 7, 2025 | |
| CI The Cigna Group | Maintains: Buy | $410 → $390 | $330.19 | +18.11% | 11 | Feb 3, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $166 → $170 | $163.77 | +3.80% | 13 | Feb 3, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $293 → $286 | $217.06 | +31.76% | 2 | Jan 28, 2025 | |
| EVH Evolent Health | Maintains: Buy | $27 → $14 | $8.97 | +56.08% | 2 | Jan 16, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $35 → $27 | $12.84 | +110.28% | 9 | Dec 3, 2024 | |
| CVS CVS Health | Maintains: Neutral | $60 → $62 | $67.28 | -7.85% | 6 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $285 | $286.94 | -0.68% | 1 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $134 → $139 | $134.68 | +3.21% | 15 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $12 | $19.43 | -38.24% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $10.80 | -7.41% | 14 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $680 → $650 | $454.11 | +43.14% | 11 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $264.38 | -5.44% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $7.5 | $6.70 | +11.94% | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $8.5 | $4.48 | +89.94% | 3 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $12 | $6.99 | +71.67% | 2 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $620 → $630 | $697.08 | -9.62% | 13 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $280 → $320 | $171.41 | +86.69% | 17 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $60.68 | +30.19% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $29 | $31.33 | -7.44% | 2 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $26 | $19.45 | +33.68% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $424.53 | +35.44% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $157.44 | +14.33% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $6.83 | +954.17% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $13.64 | -19.33% | 4 | May 4, 2021 |
Envista Holdings
Mar 10, 2025
Maintains: Neutral
Price Target: $23 → $21
Current: $15.19
Upside: +38.25%
Henry Schein
Feb 26, 2025
Maintains: Neutral
Price Target: $83 → $80
Current: $64.28
Upside: +24.46%
Owens & Minor
Feb 13, 2025
Maintains: Buy
Price Target: $25 → $13
Current: $6.65
Upside: +95.49%
Molina Healthcare
Feb 7, 2025
Maintains: Neutral
Price Target: $330 → $305
Current: $322.37
Upside: -5.39%
The Cigna Group
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $330.19
Upside: +18.11%
Quest Diagnostics
Feb 3, 2025
Maintains: Neutral
Price Target: $166 → $170
Current: $163.77
Upside: +3.80%
Labcorp Holdings
Jan 28, 2025
Maintains: Buy
Price Target: $293 → $286
Current: $217.06
Upside: +31.76%
Evolent Health
Jan 16, 2025
Maintains: Buy
Price Target: $27 → $14
Current: $8.97
Upside: +56.08%
DENTSPLY SIRONA
Dec 3, 2024
Maintains: Buy
Price Target: $35 → $27
Current: $12.84
Upside: +110.28%
CVS Health
Nov 7, 2024
Maintains: Neutral
Price Target: $60 → $62
Current: $67.28
Upside: -7.85%
Nov 7, 2024
Maintains: Buy
Price Target: $275 → $285
Current: $286.94
Upside: -0.68%
Nov 4, 2024
Maintains: Buy
Price Target: $134 → $139
Current: $134.68
Upside: +3.21%
Oct 30, 2024
Maintains: Neutral
Price Target: $9 → $12
Current: $19.43
Upside: -38.24%
Oct 17, 2024
Maintains: Neutral
Price Target: $9 → $10
Current: $10.80
Upside: -7.41%
Oct 16, 2024
Maintains: Buy
Price Target: $680 → $650
Current: $454.11
Upside: +43.14%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $264.38
Upside: -5.44%
Aug 15, 2024
Maintains: Neutral
Price Target: $9 → $7.5
Current: $6.70
Upside: +11.94%
Aug 9, 2024
Maintains: Neutral
Price Target: $9 → $8.5
Current: $4.48
Upside: +89.94%
May 23, 2024
Maintains: Neutral
Price Target: $30 → $12
Current: $6.99
Upside: +71.67%
May 8, 2024
Maintains: Buy
Price Target: $620 → $630
Current: $697.08
Upside: -9.62%
Apr 15, 2024
Maintains: Neutral
Price Target: $280 → $320
Current: $171.41
Upside: +86.69%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $60.68
Upside: +30.19%
Nov 30, 2023
Maintains: Neutral
Price Target: $33 → $29
Current: $31.33
Upside: -7.44%
Aug 23, 2023
Maintains: Neutral
Price Target: $29 → $26
Current: $19.45
Upside: +33.68%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $424.53
Upside: +35.44%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $157.44
Upside: +14.33%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $6.83
Upside: +954.17%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $13.64
Upside: -19.33%